6.
Kalkhoran S, Levy D, Rigotti N
. Smoking and E-Cigarette Use Among U.S. Adults During the COVID-19 Pandemic. Am J Prev Med. 2021; 62(3):341-349.
PMC: 8492610.
DOI: 10.1016/j.amepre.2021.08.018.
View
7.
Kaur G, Lungarella G, Rahman I
. SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping. J Inflamm (Lond). 2020; 17:21.
PMC: 7284674.
DOI: 10.1186/s12950-020-00250-8.
View
8.
White A, Li D, Snell L, OConnor R, Hoetger C, Croft D
. Perceptions of Tobacco Product-Specific COVID-19 Risk and Changes in Tobacco Use Behaviors Among Smokers, E-Cigarette Users, and Dual Users. Nicotine Tob Res. 2021; 23(9):1617-1622.
PMC: 8083727.
DOI: 10.1093/ntr/ntab053.
View
9.
Bragdon L, Diefenbach G, Hannan S, Tolin D
. Psychometric properties of the Overall Anxiety Severity and Impairment Scale (OASIS) among psychiatric outpatients. J Affect Disord. 2016; 201:112-5.
DOI: 10.1016/j.jad.2016.05.005.
View
10.
Gotts J, Jordt S, McConnell R, Tarran R
. What are the respiratory effects of e-cigarettes?. BMJ. 2019; 366:l5275.
PMC: 7850161.
DOI: 10.1136/bmj.l5275.
View
11.
Streck J, Kalkhoran S, Bearnot B, Gupta P, Kalagher K, Regan S
. Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic. Drug Alcohol Depend. 2020; 218:108438.
PMC: 7687365.
DOI: 10.1016/j.drugalcdep.2020.108438.
View
12.
Herbec A, Brown J, Jackson S, Kale D, Zatonski M, Garnett C
. Perceived risk factors for severe Covid-19 symptoms and their association with health behaviours: Findings from the HEBECO study. Acta Psychol (Amst). 2021; 222:103458.
PMC: 8639445.
DOI: 10.1016/j.actpsy.2021.103458.
View
13.
Papp L, Kouros C
. Effect of COVID-19 disruptions on young adults' affect and substance use in daily life. Psychol Addict Behav. 2021; 35(4):391-401.
PMC: 8184623.
DOI: 10.1037/adb0000748.
View
14.
Mallis N, Dailey C, Drewry S, Howard N, Cordero J, Welton M
. SARS-CoV-2 infection and e-cigarette use, binge drinking, and other associated risk factors in a college population. J Am Coll Health. 2022; 72(2):366-370.
DOI: 10.1080/07448481.2022.2053133.
View
15.
Bentley K, Gallagher M, Carl J, Barlow D
. Development and validation of the Overall Depression Severity and Impairment Scale. Psychol Assess. 2014; 26(3):815-830.
DOI: 10.1037/a0036216.
View
16.
McLeish A, Smit T, Garey L, Zvolensky M
. Anxiety Sensitivity and Emotion Dysregulation in Dual and Exclusive E-Cigarette Users. Subst Use Misuse. 2021; 56(12):1825-1830.
DOI: 10.1080/10826084.2021.1954028.
View
17.
Kassel J, Stroud L, Paronis C
. Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychol Bull. 2003; 129(2):270-304.
DOI: 10.1037/0033-2909.129.2.270.
View
18.
Ito M, Bentley K, Oe Y, Nakajima S, Fujisato H, Kato N
. Assessing depression related severity and functional impairment: the Overall Depression Severity and Impairment Scale (ODSIS). PLoS One. 2015; 10(4):e0122969.
PMC: 4395441.
DOI: 10.1371/journal.pone.0122969.
View
19.
Foulds J, Veldheer S, Yingst J, Hrabovsky S, Wilson S, Nichols T
. Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking E-cigarette users. Nicotine Tob Res. 2014; 17(2):186-92.
PMC: 4838001.
DOI: 10.1093/ntr/ntu204.
View
20.
Moore S, Welch S, Michonski J, Poquiz J, Osborne T, Sayrs J
. Psychometric evaluation of the Overall Anxiety Severity And Impairment Scale (OASIS) in individuals seeking outpatient specialty treatment for anxiety-related disorders. J Affect Disord. 2015; 175:463-70.
DOI: 10.1016/j.jad.2015.01.041.
View